US 8034812
Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof
granted A61PA61P11/06A61P13/12
Quick answer
US patent 8034812 (Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P11/06, A61P13/12, A61P15/08, A61P17/06